Skip to main content

NEUPRO® (rotigotine transdermal system) is a prescription medicine used to treat Parkinson’s disease.

Start saving today 

Follow these easy steps to SAVE on your prescription:

Saving card

NEUPRO Patient Savings Card will expire at the end of the calendar year

  • Check your eligibility below
  • Register to activate your card
  • Present your card at the pharmacy to save on your prescription

*See Eligibility Criteria and Terms

Check to see if you're eligible for the
NEUPRO Patient Savings Card.

Please provide a response to all questions before checking your eligibility.

Which of the following best describes you?

Enter the patient’s date of birth:

Are you a resident of the United States or Puerto Rico?

To be eligible for the NEUPRO Patient Savings Program you must be a resident of the United States or Puerto Rico.

Does the patient currently have commercial (also known as private) insurance?

Is the patient currently enrolled in an employer-sponsored health plan for retirees, in a prescription drug benefit program for retirees, or in any state or federal health care program, including but not limited to Medicare, Medicaid, Medigap, VA, DOD, or TRICARE?

This includes, but is not limited to:
- Medicare or Medicaid
- VA

Sorry, you are not eligible at this time.

  • This program is valid only for residents of the United States or Puerto Rico
  • This program is not available for patients without commercial insurance
  • Patients are not eligible if their prescriptions are paid in part or in full by any state or federally funded programs, including but not limited to Medicare or Medicaid, Medigap, VA, DOD, or TRICARE, and where prohibited by law
  • You must be 18 years of age or older

For more information, call us at 1-844-599-CARE (2273), Monday-Thursday, 8 AM-8 PM ET and Friday, 8 AM-5 PM ET.


You're eligible to start saving on your NEUPRO prescription. Please fill out the registration form below to activate your NEUPRO Patient Savings Card. It will only take a few minutes.

*See Eligibility Criteria
and Terms


  • This savings card is not valid for use by patients who are covered by any federally funded or state-funded healthcare program (including, but not limited to, Medicare [Part D and Medigap] and those who are Medicare-eligible and enrolled in an employer-sponsored health plan for retirees, Medicaid, any state pharmaceutical assistance program, TRICARE, VA or DoD), or for cash-paying patients. Offer good only in the U.S., including Puerto Rico. This card is good for use only with a valid NEUPRO prescription consistent with the approved FDA labeling at the time the prescription is filled by the pharmacist and dispensed to the patient. The maximum annual benefit amount is $1500 per calendar year. Void where prohibited by law, taxed, or restricted. This offer cannot be combined with any other promotional offer. UCB, Inc. reserves the right to rescind, revoke, or amend this offer without notice at any time. No cash value. Not eligible for sale, purchase, trade, or counterfeit.


  • When you use this card, you are certifying that you meet the complete Eligibility Criteria and Terms and that you have not submitted, and will not submit, a claim for reimbursement under any federal, state, or other governmental programs for this prescription. If you have any questions regarding the NEUPRO Patient Savings Program™ or wish to discontinue your participation, please call 1-855-841-0263 (8 a.m.-8 p.m. ET, Monday – Friday).


  • Your acceptance of this card and your submission of claims for the NEUPRO Patient Savings Program are subject to the LoyaltyScript® program Terms and Conditions posted at Submit transaction to RxC Acquisition Company d/b/a RxCrossroads by McKesson using BIN #610524. Input card information as secondary coverage and transmit using the COB segment of the NCPDP transaction. Applicable discounts will be displayed in the transaction response. The LoyaltyScript® card is not valid for use with any other prescription drug discount or cash cards for NEUPRO. Claims submitted utilizing the program are subject to audit or validation.

UCB reserves the right to change or cancel this program at any time without notice.

Patient Assistance Program UCB, the maker of NEUPRO, remains committed to helping Parkinson's disease patients gain access to the medicines we manufacture. The NEUPRO Patient Assistance Program may be able to help if you do not have health insurance or if you otherwise cannot afford your NEUPRO medicine.
The NEUPRO Patient Assistance Program may provide medication at no cost to eligible patients who are unable to pay for their NEUPRO prescription.
To find out if you might be eligible for assistance, or to learn more about the NEUPRO Patient Assistance Program, contact ucbCARES®.
Get started by reviewing the program instructions and filling out the application form.

As a caregiver, please fill out all information relevant to the patient you are representing.

To be eligible for the NEUPRO Patient Savings Program™, you must be a resident of the United States or Puerto Rico.
Select the statement that best describes you or the person you are representing:

By providing this information, you are representing that you are a US resident at least 18 years old and giving UCB and its business partners permission to send you information regarding your disease as well as information on other related treatments, products and services, and for marketing and informational purposes. You understand that UCB or its business partners will not sell your name, address, email address, or any other information to another party for their own marketing use. You may remove yourself from the mailing list at any time by unsubscribing from our eNewsletters as well as through a link in the privacy policy.


NEUPRO is a prescription medicine used to treat Parkinson's disease.

Important Safety Information

NEUPRO contains a sulfite called sodium metabisulfite. Sulfites can cause severe allergic reactions that are life threatening to some people who are sensitive to sulfites. People with asthma are more sensitive to sulfites. Remove the patch right away and call your doctor if you have swelling of the lips or tongue, chest pain, or trouble breathing or swallowing.

NEUPRO may make you fall asleep suddenly or without warning while doing normal activities, such as driving, which may result in accidents. Tell your doctor right away if this happens. Drinking alcohol or taking other medicines that cause drowsiness may increase your chances of becoming sleepy while using NEUPRO. Do not drive, use hazardous machinery, or do other dangerous activities until you know how NEUPRO affects you.

NEUPRO can cause or worsen psychotic symptoms including hallucinations (seeing or hearing things that are not real), confusion, excessive suspicion, aggressive behavior, agitation, delusional beliefs (believing things that are not real), and disorganized thinking. The chances of having hallucinations or these other psychotic-like changes are higher in people with Parkinson's disease who are elderly, taking NEUPRO, or taking higher doses of NEUPRO. If you have any of these problems, talk to your doctor.

NEUPRO can cause decreases in blood pressure, especially when you start or increase your dose. Increases in blood pressure and heart rate, fainting, weight gain, and fluid retention also can occur. If you faint or feel dizzy, nauseated, or sweaty when you stand up from sitting or lying down, or have an unusually fast increase in weight, swelling, or fluid retention, especially in the ankles or legs, tell your doctor.

Some patients using NEUPRO get urges to behave in a way that is unusual for them, such as unusual urges to gamble, strong urges to spend money, binge eating, or increased sexual urges and behaviors. Some patients may want to use more NEUPRO than prescribed for their symptoms (dopamine dysregulation syndrome). If you or your family notices you are developing any unusual behaviors, talk to your doctor.

NEUPRO may cause uncontrolled, sudden movements or make such movements you already have worse or more frequent if you have Parkinson's disease, which may mean that your anti-Parkinson's medicine needs to be changed.

Skin reactions may occur at the site where you apply NEUPRO. Tell your doctor if you get a rash, redness, swelling, or itching that will not go away.

Avoid exposing the NEUPRO patch you are wearing to heating pads, electric blankets, heat lamps, saunas, hot tubs, heated water beds, and direct sunlight. Too much medicine could be absorbed into your body. Also, do not wear NEUPRO during medical procedures called magnetic resonance imaging (MRI) or cardioversion because this could cause skin burns.

Do not stop using NEUPRO without talking to your doctor first. If your doctor tells you to stop using NEUPRO, you should ask your doctor for specific instructions on how to slowly and safely discontinue using NEUPRO. If you stop using NEUPRO, you may have withdrawal symptoms such as fever, confusion, severe muscle stiffness, feeling like you do not care about the things you usually care about (apathy), anxiety, depression, fatigue, insomnia, sweating and pain.

Tell your doctor if you have breathing problems, a sleep disorder, mental problems, high or low blood pressure, or heart problems; are pregnant or plan to become pregnant; or are breastfeeding or plan to breastfeed. NEUPRO may not be right for you.

The most common side effects in people taking NEUPRO for Parkinson's disease are nausea, vomiting, sleepiness, application site reactions, dizziness, loss of appetite, difficulty falling asleep and staying asleep, increased sweating, vision problems, leg swelling, and uncontrolled, sudden movements of the arms or legs.

These are not all the possible side effects of NEUPRO. For more information, ask your doctor or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088. You may also report side effects to UCB, Inc. at ucbCARES® (1-844-599-2273).

Please see additional Patient Information about the NEUPRO Patch. This information does not take the place of talking with your healthcare provider about your condition or treatment.